Michael Lee Brooks - 18 Jan 2022 Form 4 Insider Report for Syneos Health, Inc.

Role: Chief Development Officer, Clinical Solutions
Signature: /s/ Sara Epstein, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 18 Jan 2022
Net transactions value: -$207,477
Form type: 4
Filing time: 20 Jan 2022, 16:15:51 UTC
Previous filing: 03 Jan 2022
Next filing: 18 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SYNH	Class A Common Stock	Tax liability	$95,904	-1,114	-3.4%	$86.09	31,885	18 Jan 2022	Direct
transaction	SYNH	Class A Common Stock	Award	$0	+7,415	+23%	$0.000000	39,300	18 Jan 2022	Direct	F1
transaction	SYNH	Class A Common Stock	Tax liability	$111,573	-1,296	-15%	$86.09	7,442	18 Jan 2022	By spouse
transaction	SYNH	Class A Common Stock	Award	$0	+3,400	+46%	$0.000000	10,842	18 Jan 2022	By spouse	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of restricted stock units which vests in three approximately equal annual installments of 33 1/3% beginning on January 18, 2023, subject to continued employment.

Remarks:

Chief Development Officer, Clinical Solutions